Global and China Anti-Infective Vaccines Market Insights, Forecast to 2026

Publisher Name :
Date: 17-Sep-2020
No. of pages: 142
Inquire Before Buying

Anti-Infective Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Infective Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Anti-Infective Vaccines market is segmented into

- Inactivated vaccines

- Conjugate vaccines

- Live/attenuated vaccines

Segment by Application, the Anti-Infective Vaccines market is segmented into

- Bacterial diseases

- Viral diseases

Regional and Country-level Analysis

The Anti-Infective Vaccines market is analysed and market size information is provided by regions (countries).

The key regions covered in the Anti-Infective Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Anti-Infective Vaccines Market Share Analysis

Anti-Infective Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Infective Vaccines business, the date to enter into the Anti-Infective Vaccines market, Anti-Infective Vaccines product introduction, recent developments, etc.

The major vendors covered:

- Emergent BioDefense Operations Lansing Inc.

- Sanofi Pasteur

- Merck & Co.

- MedImmune LLC

- Novartis Vaccines

- Diagnostics Ltd.

- Intercell Biomedical

- MassBiologics

- Barr Labs, Inc.

- Organon Teknika Co.

- GlaxoSmithKline Biologicals

- CSL Ltd.

- ID Biomedical Co.

- Protein Sciences Co.

- Wyeth Pharmaceuticals, Inc.

- Berna Biotech

Global and China Anti-Infective Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Anti-Infective Vaccines Product Introduction
1.2 Market Segments
1.3 Key Anti-Infective Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Infective Vaccines Market Size Growth Rate by Type
1.4.2 Inactivated vaccines
1.4.3 Conjugate vaccines
1.4.4 Live/attenuated vaccines
1.5 Market by Application
1.5.1 Global Anti-Infective Vaccines Market Size Growth Rate by Application
1.5.2 Bacterial diseases
1.5.3 Viral diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Infective Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Anti-Infective Vaccines Revenue 2015-2026
2.1.2 Global Anti-Infective Vaccines Sales 2015-2026
2.2 Global Anti-Infective Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Anti-Infective Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Anti-Infective Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Anti-Infective Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Anti-Infective Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Anti-Infective Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Anti-Infective Vaccines Revenue Forecast by Region (2021-2026)
3 Global Anti-Infective Vaccines Competitor Landscape by Players
3.1 Global Top Anti-Infective Vaccines Sales by Manufacturers
3.1.1 Global Anti-Infective Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Anti-Infective Vaccines Manufacturers by Revenue
3.2.1 Global Anti-Infective Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti-Infective Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Infective Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Infective Vaccines Revenue in 2019
3.2.5 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anti-Infective Vaccines Price by Manufacturers
3.4 Global Anti-Infective Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Infective Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Infective Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Infective Vaccines Market Size by Type (2015-2020)
4.1.1 Global Anti-Infective Vaccines Sales by Type (2015-2020)
4.1.2 Global Anti-Infective Vaccines Revenue by Type (2015-2020)
4.1.3 Anti-Infective Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Infective Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Infective Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Infective Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Infective Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Infective Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Infective Vaccines Market Size by Application (2015-2020)
5.1.1 Global Anti-Infective Vaccines Sales by Application (2015-2020)
5.1.2 Global Anti-Infective Vaccines Revenue by Application (2015-2020)
5.1.3 Anti-Infective Vaccines Price by Application (2015-2020)
5.2 Anti-Infective Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Infective Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Infective Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Infective Vaccines Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Anti-Infective Vaccines Market Size YoY Growth 2015-2026
6.1.1 China Anti-Infective Vaccines Sales YoY Growth 2015-2026
6.1.2 China Anti-Infective Vaccines Revenue YoY Growth 2015-2026
6.1.3 China Anti-Infective Vaccines Market Share in Global Market 2015-2026
6.2 China Anti-Infective Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top Anti-Infective Vaccines Players by Sales (2015-2020)
6.2.2 China Top Anti-Infective Vaccines Players by Revenue (2015-2020)
6.3 China Anti-Infective Vaccines Historic Market Review by Type (2015-2020)
6.3.1 China Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
6.3.2 China Anti-Infective Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 China Anti-Infective Vaccines Price by Type (2015-2020)
6.4 China Anti-Infective Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Anti-Infective Vaccines Sales Forecast by Type (2021-2026)
6.4.2 China Anti-Infective Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 China Anti-Infective Vaccines Price Forecast by Type (2021-2026)
6.5 China Anti-Infective Vaccines Historic Market Review by Application (2015-2020)
6.5.1 China Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
6.5.2 China Anti-Infective Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 China Anti-Infective Vaccines Price by Application (2015-2020)
6.6 China Anti-Infective Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Anti-Infective Vaccines Sales Forecast by Application (2021-2026)
6.6.2 China Anti-Infective Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 China Anti-Infective Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Anti-Infective Vaccines Market Size YoY Growth 2015-2026
7.2 North America Anti-Infective Vaccines Market Facts & Figures by Country
7.2.1 North America Anti-Infective Vaccines Sales by Country (2015-2020)
7.2.2 North America Anti-Infective Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Anti-Infective Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Anti-Infective Vaccines Market Facts & Figures by Country
8.2.1 Europe Anti-Infective Vaccines Sales by Country
8.2.2 Europe Anti-Infective Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Anti-Infective Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Anti-Infective Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Anti-Infective Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Anti-Infective Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Anti-Infective Vaccines Market Facts & Figures by Country
10.2.1 Latin America Anti-Infective Vaccines Sales by Country
10.2.2 Latin America Anti-Infective Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Anti-Infective Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Anti-Infective Vaccines Sales by Country
11.2.2 Middle East and Africa Anti-Infective Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Emergent BioDefense Operations Lansing Inc.
12.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
12.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
12.1.3 Emergent BioDefense Operations Lansing Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
12.1.5 Emergent BioDefense Operations Lansing Inc. Recent Development
12.2 Sanofi Pasteur
12.2.1 Sanofi Pasteur Corporation Information
12.2.2 Sanofi Pasteur Description and Business Overview
12.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Pasteur Anti-Infective Vaccines Products Offered
12.2.5 Sanofi Pasteur Recent Development
12.3 Merck & Co.
12.3.1 Merck & Co. Corporation Information
12.3.2 Merck & Co. Description and Business Overview
12.3.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck & Co. Anti-Infective Vaccines Products Offered
12.3.5 Merck & Co. Recent Development
12.4 MedImmune LLC
12.4.1 MedImmune LLC Corporation Information
12.4.2 MedImmune LLC Description and Business Overview
12.4.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
12.4.4 MedImmune LLC Anti-Infective Vaccines Products Offered
12.4.5 MedImmune LLC Recent Development
12.5 Novartis Vaccines
12.5.1 Novartis Vaccines Corporation Information
12.5.2 Novartis Vaccines Description and Business Overview
12.5.3 Novartis Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Vaccines Anti-Infective Vaccines Products Offered
12.5.5 Novartis Vaccines Recent Development
12.6 Diagnostics Ltd.
12.6.1 Diagnostics Ltd. Corporation Information
12.6.2 Diagnostics Ltd. Description and Business Overview
12.6.3 Diagnostics Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products Offered
12.6.5 Diagnostics Ltd. Recent Development
12.7 Intercell Biomedical
12.7.1 Intercell Biomedical Corporation Information
12.7.2 Intercell Biomedical Description and Business Overview
12.7.3 Intercell Biomedical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Intercell Biomedical Anti-Infective Vaccines Products Offered
12.7.5 Intercell Biomedical Recent Development
12.8 MassBiologics
12.8.1 MassBiologics Corporation Information
12.8.2 MassBiologics Description and Business Overview
12.8.3 MassBiologics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 MassBiologics Anti-Infective Vaccines Products Offered
12.8.5 MassBiologics Recent Development
12.9 Barr Labs, Inc.
12.9.1 Barr Labs, Inc. Corporation Information
12.9.2 Barr Labs, Inc. Description and Business Overview
12.9.3 Barr Labs, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products Offered
12.9.5 Barr Labs, Inc. Recent Development
12.10 Organon Teknika Co.
12.10.1 Organon Teknika Co. Corporation Information
12.10.2 Organon Teknika Co. Description and Business Overview
12.10.3 Organon Teknika Co. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Organon Teknika Co. Anti-Infective Vaccines Products Offered
12.10.5 Organon Teknika Co. Recent Development
12.11 Emergent BioDefense Operations Lansing Inc.
12.11.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
12.11.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
12.11.3 Emergent BioDefense Operations Lansing Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
12.11.5 Emergent BioDefense Operations Lansing Inc. Recent Development
12.12 CSL Ltd.
12.12.1 CSL Ltd. Corporation Information
12.12.2 CSL Ltd. Description and Business Overview
12.12.3 CSL Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 CSL Ltd. Products Offered
12.12.5 CSL Ltd. Recent Development
12.13 ID Biomedical Co.
12.13.1 ID Biomedical Co. Corporation Information
12.13.2 ID Biomedical Co. Description and Business Overview
12.13.3 ID Biomedical Co. Sales, Revenue and Gross Margin (2015-2020)
12.13.4 ID Biomedical Co. Products Offered
12.13.5 ID Biomedical Co. Recent Development
12.14 Protein Sciences Co.
12.14.1 Protein Sciences Co. Corporation Information
12.14.2 Protein Sciences Co. Description and Business Overview
12.14.3 Protein Sciences Co. Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Protein Sciences Co. Products Offered
12.14.5 Protein Sciences Co. Recent Development
12.15 Wyeth Pharmaceuticals, Inc.
12.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
12.15.2 Wyeth Pharmaceuticals, Inc. Description and Business Overview
12.15.3 Wyeth Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Wyeth Pharmaceuticals, Inc. Products Offered
12.15.5 Wyeth Pharmaceuticals, Inc. Recent Development
12.16 Berna Biotech
12.16.1 Berna Biotech Corporation Information
12.16.2 Berna Biotech Description and Business Overview
12.16.3 Berna Biotech Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Berna Biotech Products Offered
12.16.5 Berna Biotech Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Anti-Infective Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Infective Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Anti-Infective Vaccines Market Segments
Table 2. Ranking of Global Top Anti-Infective Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Infective Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Inactivated vaccines
Table 5. Major Manufacturers of Conjugate vaccines
Table 6. Major Manufacturers of Live/attenuated vaccines
Table 7. Global Anti-Infective Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Anti-Infective Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-Infective Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global Anti-Infective Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-Infective Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-Infective Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Anti-Infective Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Anti-Infective Vaccines Sales Share by Manufacturers (2015-2020)
Table 15. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Vaccines as of 2019)
Table 17. Anti-Infective Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Anti-Infective Vaccines Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Anti-Infective Vaccines Price (2015-2020) (USD/Unit)
Table 20. Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Anti-Infective Vaccines Product Type
Table 22. Date of International Manufacturers Enter into Anti-Infective Vaccines Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Infective Vaccines Sales by Type (2015-2020) (K Units)
Table 25. Global Anti-Infective Vaccines Sales Share by Type (2015-2020)
Table 26. Global Anti-Infective Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Anti-Infective Vaccines Revenue Share by Type (2015-2020)
Table 28. Anti-Infective Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Anti-Infective Vaccines Sales Share by Type (2021-2026)
Table 30. Global Anti-Infective Vaccines Sales by Application (2015-2020) (K Units)
Table 31. Global Anti-Infective Vaccines Sales Share by Application (2015-2020)
Table 32. Global Anti-Infective Vaccines Sales Share by Application (2021-2026)
Table 33. Global Anti-Infective Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Anti-Infective Vaccines Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Anti-Infective Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 36. China Anti-Infective Vaccines Sales (K Units) of Key Companies (2015-2020)
Table 37. China Anti-Infective Vaccines Sales Share by Company (2015-2020)
Table 38. China Anti-Infective Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 39. China Anti-Infective Vaccines Sales (K Units) by Type (2015-2020)
Table 40. China Anti-Infective Vaccines Sales Share by Type (2015-2020)
Table 41. China Anti-Infective Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. China Anti-Infective Vaccines Price (K Units) by Type (2015-2020)
Table 43. China Anti-Infective Vaccines Sales (K Units) by Type (2021-2026)
Table 44. China Anti-Infective Vaccines Sales Share by Type (2021-2026)
Table 45. China Anti-Infective Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. China Anti-Infective Vaccines Revenue Share by Type (2021-2026)
Table 47. China Anti-Infective Vaccines Price (K Units) by Type (2021-2026)
Table 48. China Anti-Infective Vaccines Sales (K Units) by Application (2015-2020)
Table 49. China Anti-Infective Vaccines Sales Share by Application (2015-2020)
Table 50. China Anti-Infective Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. China Anti-Infective Vaccines Sales (K Units) by Application (2021-2026)
Table 52. China Anti-Infective Vaccines Sales Share by Application (2021-2026)
Table 53. China Anti-Infective Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. China Anti-Infective Vaccines Revenue Share by Application (2021-2026)
Table 55. North America Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 56. North America Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 57. North America Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 59. Europe Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 60. Europe Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 61. Europe Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Anti-Infective Vaccines Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Anti-Infective Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region (2015-2020)
Table 67. Latin America Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 68. Latin America Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 75. Emergent BioDefense Operations Lansing Inc. Corporation Information
Table 76. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
Table 77. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product
Table 79. Emergent BioDefense Operations Lansing Inc. Recent Development
Table 80. Sanofi Pasteur Corporation Information
Table 81. Sanofi Pasteur Description and Business Overview
Table 82. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Pasteur Product
Table 84. Sanofi Pasteur Recent Development
Table 85. Merck & Co. Corporation Information
Table 86. Merck & Co. Description and Business Overview
Table 87. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merck & Co. Product
Table 89. Merck & Co. Recent Development
Table 90. MedImmune LLC Corporation Information
Table 91. MedImmune LLC Description and Business Overview
Table 92. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. MedImmune LLC Product
Table 94. MedImmune LLC Recent Development
Table 95. Novartis Vaccines Corporation Information
Table 96. Novartis Vaccines Description and Business Overview
Table 97. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novartis Vaccines Product
Table 99. Novartis Vaccines Recent Development
Table 100. Diagnostics Ltd. Corporation Information
Table 101. Diagnostics Ltd. Description and Business Overview
Table 102. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Diagnostics Ltd. Product
Table 104. Diagnostics Ltd. Recent Development
Table 105. Intercell Biomedical Corporation Information
Table 106. Intercell Biomedical Description and Business Overview
Table 107. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Intercell Biomedical Product
Table 109. Intercell Biomedical Recent Development
Table 110. MassBiologics Corporation Information
Table 111. MassBiologics Description and Business Overview
Table 112. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. MassBiologics Product
Table 114. MassBiologics Recent Development
Table 115. Barr Labs, Inc. Corporation Information
Table 116. Barr Labs, Inc. Description and Business Overview
Table 117. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Barr Labs, Inc. Product
Table 119. Barr Labs, Inc. Recent Development
Table 120. Organon Teknika Co. Corporation Information
Table 121. Organon Teknika Co. Description and Business Overview
Table 122. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Organon Teknika Co. Product
Table 124. Organon Teknika Co. Recent Development
Table 125. GlaxoSmithKline Biologicals Corporation Information
Table 126. GlaxoSmithKline Biologicals Description and Business Overview
Table 127. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. GlaxoSmithKline Biologicals Product
Table 129. GlaxoSmithKline Biologicals Recent Development
Table 130. CSL Ltd. Corporation Information
Table 131. CSL Ltd. Description and Business Overview
Table 132. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. CSL Ltd. Product
Table 134. CSL Ltd. Recent Development
Table 135. ID Biomedical Co. Corporation Information
Table 136. ID Biomedical Co. Description and Business Overview
Table 137. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. ID Biomedical Co. Product
Table 139. ID Biomedical Co. Recent Development
Table 140. Protein Sciences Co. Corporation Information
Table 141. Protein Sciences Co. Description and Business Overview
Table 142. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Protein Sciences Co. Product
Table 144. Protein Sciences Co. Recent Development
Table 145. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 146. Wyeth Pharmaceuticals, Inc. Description and Business Overview
Table 147. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Wyeth Pharmaceuticals, Inc. Product
Table 149. Wyeth Pharmaceuticals, Inc. Recent Development
Table 150. Berna Biotech Corporation Information
Table 151. Berna Biotech Description and Business Overview
Table 152. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Berna Biotech Product
Table 154. Berna Biotech Recent Development
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Anti-Infective Vaccines Players
Table 159. Anti-Infective Vaccines Customers List
Table 160. Anti-Infective Vaccines Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Infective Vaccines Product Picture
Figure 2. Global Anti-Infective Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Inactivated vaccines Product Picture
Figure 4. Conjugate vaccines Product Picture
Figure 5. Live/attenuated vaccines Product Picture
Figure 6. Global Anti-Infective Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Bacterial diseases
Figure 8. Viral diseases
Figure 9. Anti-Infective Vaccines Report Years Considered
Figure 10. Global Anti-Infective Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global Anti-Infective Vaccines Sales 2015-2026 (K Units)
Figure 12. Global Anti-Infective Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Anti-Infective Vaccines Sales Market Share by Region (2015-2020)
Figure 14. Global Anti-Infective Vaccines Sales Market Share by Region in 2019
Figure 15. Global Anti-Infective Vaccines Revenue Market Share by Region (2015-2020)
Figure 16. Global Anti-Infective Vaccines Revenue Market Share by Region in 2019
Figure 17. Global Anti-Infective Vaccines Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Anti-Infective Vaccines Revenue in 2019
Figure 19. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
Figure 21. Global Anti-Infective Vaccines Sales Market Share by Type in 2019
Figure 22. Global Anti-Infective Vaccines Revenue Market Share by Type (2015-2020)
Figure 23. Global Anti-Infective Vaccines Revenue Market Share by Type in 2019
Figure 24. Global Anti-Infective Vaccines Market Share by Price Range (2015-2020)
Figure 25. Global Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Figure 26. Global Anti-Infective Vaccines Sales Market Share by Application in 2019
Figure 27. Global Anti-Infective Vaccines Revenue Market Share by Application (2015-2020)
Figure 28. Global Anti-Infective Vaccines Revenue Market Share by Application in 2019
Figure 29. China Anti-Infective Vaccines Sales Growth Rate 2015-2026 (K Units)
Figure 30. China Anti-Infective Vaccines Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. China Anti-Infective Vaccines Market Share in Global Market 2015-2026
Figure 32. China 5 and 10 Largest Anti-Infective Vaccines Players Market Share by Revenue in Anti-Infective Vaccines in 2019
Figure 33. China Anti-Infective Vaccines Revenue Share by Type (2015-2020)
Figure 34. China Anti-Infective Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 35. China Anti-Infective Vaccines Revenue Share by Application (2015-2020)
Figure 36. China Anti-Infective Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Anti-Infective Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Anti-Infective Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Anti-Infective Vaccines Sales Market Share by Country in 2019
Figure 40. North America Anti-Infective Vaccines Revenue Market Share by Country in 2019
Figure 41. U.S. Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Anti-Infective Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Anti-Infective Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Anti-Infective Vaccines Sales Market Share by Country in 2019
Figure 48. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2019
Figure 49. Germany Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Anti-Infective Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Anti-Infective Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region in 2019
Figure 62. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region in 2019
Figure 63. China Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Anti-Infective
  • Global Medical Cannabis Oil Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Medical Cannabis Oil market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Cannabis Oil business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Cannabis Oil market by ......
  • Global Medical Use Empty Capsules Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 161
    According to this study, over the next five years the Medical Use Empty Capsules market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Use Empty Capsules business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Use Empty C......
  • Global Systemic Lupus Erythematosus (SLE) Medication Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Systemic Lupus Erythematosus (SLE) Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Systemic Lupus Erythematosus (SLE) Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growt......
  • Global Pets Vitamins and Supplements Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Pets Vitamins and Supplements market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pets Vitamins and Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pets Vitamins......
  • Global Soft Elastic Capsule Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Soft Elastic Capsule market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Soft Elastic Capsule business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Soft Elastic Capsule market by ......
  • Global Anti-worm Medication Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Anti-worm Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-worm Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-worm Medication market by ......
  • Global Albendazole Anthelmintic Drug Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Albendazole Anthelmintic Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Albendazole Anthelmintic Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Albendazole A......
  • Global Immune System Supplements Market Growth (Status and Outlook) 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 138
    According to this study, over the next five years the Immune System Supplements market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Immune System Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Immune System Supplements market......
  • Global Antipyretic Analgesics Market Growth (Status and Outlook) 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Antipyretic Analgesics market will register a 1.3%% CAGR in terms of revenue, the global market size will reach $ 2693.6 million by 2025, from $ 2561.5 million in 2019. In particular, this report presents the global revenue market share of key companies in Antipyretic Analgesics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Analgesics market......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs